Jonathan Levin, MD, MBI

Director, Bronchopulmonary Dysplasia Program; Director, Center for Healthy Infant Lung Development; Co-Director, Chronic Pulmonary and Ventilator Program; Pulmonologist, Divisions of Newborn Medicine and Pulmonary Medicine
Assistant Professor of Pediatrics, Harvard Medical School
Jonathan Levin, MD
Phone 617-355-1900
NPI 1508108119
Print Profile
View Research Profile
Locations

Jonathan Levin, MD, MBI

Director, Bronchopulmonary Dysplasia Program; Director, Center for Healthy Infant Lung Development; Co-Director, Chronic Pulmonary and Ventilator Program; Pulmonologist, Divisions of Newborn Medicine and Pulmonary Medicine
Assistant Professor of Pediatrics, Harvard Medical School

Medical Services

Programs & Services
Bronchopulmonary Dysplasia Program
Center for Healthy Infant Lung Development
Cystic Fibrosis Center
NICU Program
Pulmonary Integrated Ventilator Outpatient Team
Newborn Medicine
Pulmonary Medicine
Conditions & Treatments
Asthma
Bronchopulmonary Dysplasia
Chronic Lung Disease of Prematurity
Cystic Fibrosis
Prematurity
Tracheomalacia
Bronchoscopy
Languages
English
Education
Undergraduate School
Brown University
2008
Providence
RI
Medical School
Yale School of Medicine
2013
New Haven
CT
Internship
Pediatrics
Boston Combined Residency Program
2014
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program
2016
Boston
MA
Fellowship
Boston Children's Hospital
2020
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Neonatal-Perinatal Medicine)
American Board of Pediatrics (Pulmonology)
Professional History

I provide longitudinal care to babies born preterm from the time they are in the NICU through discharge and into childhood, with a special focus on respiratory and breathing complications of prematurity. Our team focuses on promoting healthy lung development to optimize outcomes. It gives me great satisfaction to see our infants graduate from the NICU and develop into thriving children.

Publications

Impact of Social Determinants on Home Oxygen Therapy Duration in Preterm Infants: A Study Utilizing the Childhood Opportunity Index. View Abstract
Outcomes of Ventilator-Dependent Children With Severe Bronchopulmonary Dysplasia and Tracheobronchomalacia. View Abstract
Liberation from Respiratory Support in Bronchopulmonary Dysplasia. View Abstract
Outpatient clinical care for bronchopulmonary dysplasia: A survey of the BPD collaborative. View Abstract
Outcomes of infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension who required home ventilation. View Abstract
Factors associated with liberation from home mechanical ventilation and tracheostomy decannulation in infants and children with severe bronchopulmonary dysplasia. View Abstract
Transpyloric feeding is associated with adverse in-hospital outcomes in infants with severe bronchopulmonary dysplasia. View Abstract
Number of children in the household influences respiratory morbidities in children with bronchopulmonary dysplasia in the outpatient setting. View Abstract
To Trach or Not To Trach: Long-term Tracheostomy Outcomes in Infants with BPD. View Abstract
Pre-Flight Hypoxemia Challenge Testing in Bronchopulmonary Dysplasia. View Abstract
Classifying multicenter approaches to invasive mechanical ventilation for infants with bronchopulmonary dysplasia using hierarchical clustering analysis. View Abstract
Respiratory Outcomes for Ventilator-Dependent Children With Bronchopulmonary Dysplasia. View Abstract
Beyond the NICU: Comprehensive management of infants with bronchopulmonary dysplasia in the PICU. View Abstract
Prediction of extubation failure among low birthweight neonates using machine learning. View Abstract
Tracheostomy in a Preterm Infant with Severe Bronchopulmonary Dysplasia. View Abstract
Discharge Practices for Infants with Bronchopulmonary Dysplasia: A Survey of National Experts. View Abstract
Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. View Abstract
Daycare Attendance is Linked to Increased Risk of Respiratory Morbidities in Children Born Preterm with Bronchopulmonary Dysplasia. View Abstract
Summary for Clinicians: Clinical Practice Guidelines for Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease. View Abstract
Cost Savings Without Increased Risk of Respiratory Hospitalization for Preterm Children after the 2014 Palivizumab Policy Update. View Abstract
Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia. View Abstract
Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline. View Abstract
Long-term respiratory and developmental outcomes in children with bronchopulmonary dysplasia and history of tracheostomy. View Abstract
Lung function trajectories in children with post-prematurity respiratory disease: identifying risk factors for abnormal growth. View Abstract
Medication utilization in children born preterm in the first two years of life. View Abstract
COVID-19: neonatal-perinatal perspectives. View Abstract
Apnea in the Otherwise Healthy, Term Newborn: National Prevalence and Utilization during the Birth Hospitalization. View Abstract
Locations